<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02576808</url>
  </required_header>
  <id_info>
    <org_study_id>MTU-EC-TM-4-077/57</org_study_id>
    <secondary_id>TCTR20151001001</secondary_id>
    <nct_id>NCT02576808</nct_id>
  </id_info>
  <brief_title>Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis</brief_title>
  <official_title>Comparative Study of Efficacy and Adverse Effects of Ginger Extract and Loratadine for Treatment of Allergic Rhinitis Patients (Clinical Trial Phase II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thai Traditional Medical Knowledge Fund</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thai Traditional Medical Knowledge Fund</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy and adverse effects of Ginger extract in treating allergic rhinitis patients
      compared with Loratadine.The double blind randomized controlled trial study was approved by
      the Human Research Ethics Committee of Thammasat University NO.1.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The double blind randomized controlled trial study. Patients who meet the inclusion criteria
      and do not fall into any exclusion criteria will be randomly placed into the experimental
      group, who will receive ginger extract capsules, or the control group, who will receive
      loratadine for 42 days.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nasal symptom</measure>
    <time_frame>42days</time_frame>
    <description>Nasal symptom from Total nasal symptom score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>42days</time_frame>
    <description>Quality of Life from Rhinoconjunctivitis Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal patency</measure>
    <time_frame>42days</time_frame>
    <description>Nasal patency from Acoustic rhinometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Rhinitis,Allergic</condition>
  <arm_group>
    <arm_group_label>Ginger extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Loratadine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginger extract</intervention_name>
    <description>Ginger extract capsule at dose of 250 mg two times a day after meal daily for 42 days</description>
    <arm_group_label>Ginger extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Loratadine</intervention_name>
    <description>Loratadine tablet at dose of 10 mg one times a day after morning meal daily for 42 days</description>
    <arm_group_label>Loratadine</arm_group_label>
    <other_name>Clarityne</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients have moderate allergic rhinitis (itching and nasal obstruction, watery nasal
             discharge, sneezing and congestion )with a minimum total nasal symptom score 7 point

          2. These patients do not have the respiratory disease such as tuberculosis, nasal polyps.

          3. These patients do not have the history of disease: heart disease, kidney disease,
             liver disease, epilepsy, high blood pressure and severe asthma.

          4. These patients are not pregnant or breastfeeding.

          5. These patients have normal BMI and vital signs.

        Exclusion Criteria:

          1. Those who have taken anti-coagulant and anti-platelet aggregation medications.

          2. Those who get serious side effects from Loratadine and ginger allergy.

          3. Communication problems especially listening and interview.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodsarin Yamprasert</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine Thammasat University (Rangsit Campus)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Thammasat University Hospital</name>
      <address>
        <city>Khlong Luang,</city>
        <state>Pathumthani</state>
        <zip>12120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2015</study_first_submitted>
  <study_first_submitted_qc>October 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2015</study_first_posted>
  <last_update_submitted>October 8, 2017</last_update_submitted>
  <last_update_submitted_qc>October 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thai Traditional Medical Knowledge Fund</investigator_affiliation>
    <investigator_full_name>Rodsarin Yamprasert</investigator_full_name>
    <investigator_title>Faculty of Medicine Thammasat University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Loratadine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

